Although disagreeing with our original hypothesis that higher vascular risk would be associated with greater levels of Aβ and tau, our findings suggest that vascular risk and AD neuropathology may constitute separate pathways and independently contribute to the development of cognitive impairment. The gene discussed is MAPT; the disease is Cognitive impairment.